copaydosingefficacyresourcesafety

THIS SITE IS INTENDED FOR US AUDIENCES ONLY

Request an FRM

Learn more about access and coverage options from an Otezla® (apremilast) field reimbursement manager

Main Contact Information
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320-1789
+1 805-447-1000

Medical Information
Medical questions or adverse event reports can be directed to Amgen Inc. Medical Information at:

Phone
800-77-AMGEN (800-772-6436)

Email
medinfo@amgen.com

Web
www.amgenmedinfo.com

Indications & Important Safety Information

Please click here for Full Prescribing Information.

You are leaving the Otezla® (apremilast) website

Do you wish to leave this site?

Are You a Healthcare Professional?

.marketAccessModal .lineOne, .marketAccessModal .lineTwo { font-size: 44px; text-transform: none; margin-bottom: 10px; } .marketAccessModal .lineTwo { font-size: 42px; text-transform: none; } @media screen and (max-width: 450px) { .marketAccessModal .lineOne, .marketAccessModal .lineTwo { font-size: calc(15px + 7 * ((100vw - 325px) / 125)); } }
The FDA approves a new indication for Otezla® (apremilast) Learn more about this treatment option for your patients
EXPLORE